The effect of iodine on the laboratory results was detected 9 days after the procedure and gradually corrected after piperacillin sodium was discontinued. In patients with severely impaired renal function, the half-life of diatrizoate meglumine is reported to be 20-140 h [3] . Whether piperacillin sodium can decrease the clearance of the iodinated contrast media as well is not known.
Although a common procedure, we are unaware of a case report in the literature with similar electrolyte abnormalities following a VCU. Eight children who underwent VCUs in our institution recently had serum electrolytes measured within several days of the VCU. Serum electrolytes were normal in all.
In conclusion, we report a patient who developed spurious hyperchloraemia, increased total CO2 and a negative anion gap noted 9 days after a VCU. These unexplained abnormal laboratory results suggest absorption of the contrast media across the bladder mucosa. To our knowledge this is the first case report of spurious hyperchloraemia, increased total CO2 and a negative anion gap detected following VCU in a patient with bladder exstrophy. Physicians should be aware of the possibility of absorption of radiocontrast dye following VCU, especially in the presence of severe urethral stenosis, ureteric reflux and bladder inflammation, and its possible consequences, including spurious laboratory results. Despite the increasing therapeutic use of recombinant human growth hormone (rhGH), its metabolic clearance has not been investigated in detail. To evaluate the kinetics of rhGH as a possible function of GH plasma concentration and glomerular filtration rate (GFR), we investigated the steady state metabolic clearance rate (MCR), disappearance half-life, and apparent volume of distribution of rhGH at low and high physiological as well as supraphysiological plasma GH levels during pharmacological suppression of endogenous GH secretion in human subjects with normal and reduced renal function. GH in plasma and urine was determined by an immunoradimnetric assay, and GFR by inulin clearance. In all subjects MCR decreased and plasma half-life increased with increasing plasma GH concentrations (P <0.001). MCR of rhGH was approximately half in patients with chronic renal failure at each GH level and plasma half-life was increased by 25-50%. Allowing for the linear dependence of MCR on GFR and assuming single-compartment distribution, the estimated renal fraction of total MCR was 25-53 and 4-15% in controls and patients, respectively, Saturation of extrarenal disposal of GH was suggested by an inverse hyperbolic relationship between extrarenal MCR and plasma GH concentrations in all subjects. Fractional GH excretion was up to 1,000-fold higher in patients than in controls. We conclude that MCR of hGH is a function of plasma GH concentrations and GFR. Extrarenal elimination is saturable in the upper physiological range of GH concentrations, whereas renal MCR is independent of plasma GH levels. The kidney handles GH like a microprotein involving glomerular filtration, tubular reabsorption, and urinary excretion.
